RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 84 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2014. The put-call ratio across all filers is 2.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $499,000 | +67.4% | 55,579 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $298,000 | +26.8% | 55,579 | +9.0% | 0.00% | 0.0% |
| Q1 2016 | $235,000 | -15.5% | 51,010 | -4.7% | 0.00% | 0.0% |
| Q4 2015 | $278,000 | -26.3% | 53,510 | -14.0% | 0.00% | -50.0% |
| Q3 2015 | $377,000 | -61.6% | 62,238 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $983,000 | +90.9% | 62,238 | +31.3% | 0.00% | +100.0% |
| Q1 2015 | $515,000 | +2.4% | 47,404 | -0.8% | 0.00% | 0.0% |
| Q4 2014 | $503,000 | +8.4% | 47,795 | -1.2% | 0.00% | 0.0% |
| Q3 2014 | $464,000 | -16.4% | 48,374 | +0.7% | 0.00% | 0.0% |
| Q2 2014 | $555,000 | +20.9% | 48,050 | +4.6% | 0.00% | 0.0% |
| Q1 2014 | $459,000 | -23.6% | 45,924 | -0.5% | 0.00% | -33.3% |
| Q4 2013 | $601,000 | -15.4% | 46,132 | -2.9% | 0.00% | 0.0% |
| Q3 2013 | $710,000 | +83.0% | 47,529 | +14.6% | 0.00% | +50.0% |
| Q2 2013 | $388,000 | – | 41,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |